Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: R5TH77F919

Structure

InChI Key CLHMYBJIOZXCEX-QIGVQZHLSA-N
Smile CC(C)(C(=O)NC1C2CC3CC1CC(C(N)=O)(C3)C2)N1CCN(c2ccc(C(F)(F)F)cn2)CC1
InChI
InChI=1S/C25H34F3N5O2/c1-23(2,33-7-5-32(6-8-33)19-4-3-18(14-30-19)25(26,27)28)22(35)31-20-16-9-15-10-17(20)13-24(11-15,12-16)21(29)34/h3-4,14-17,20H,5-13H2,1-2H3,(H2,29,34)(H,31,35)/t15?,16?,17?,20-,24?

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H34F3N5O2
Molecular Weight 493.57
AlogP 2.8
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 5.0
Polar Surface Area 91.56
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 35.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR 11-beta-hydroxysteroid dehydrogenase 1 inhibitor PubMed PubMed PubMed
Primary Target
hydroxysteroid 11-beta dehydrogenase 1

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Alzheimer Disease 2 D000544 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 868623-40-9
ChEMBL CHEMBL4297256
FDA SRS R5TH77F919
Guide to Pharmacology 7357
PubChem 11670435